Return to search

Leptin and left ventricular mass in a South African population of African descent

M.Sc.(Med.), Faculty of Health Sciences, University of the Witwatersrand, 2009. / Leptin is a substance that is released from adipose tissue and although it is
primarily employed to modify body size, it also targets a number of other tissues,
including the myocardium. Although plasma leptin concentrations may predict
cardiovascular risk beyond conventional measurements, it is uncertain whether this may
be explained by an independent effect on left ventricular mass (LVM) and geometry.
Previous clinical studies evaluating the independent relationship between plasma leptin
concentrations and LVM have been conducted in either small study samples (n=31-55),
in severely obese participants only, in select subgroups (with insulin resistance) or in
population samples with a relatively low mean body mass index (BMI). In the present
dissertation I therefore assessed whether plasma leptin concentrations are associated
with LVM and LV mean wall thickness independent of adiposity indices in 378 adults of
African descent randomly recruited from a population sample with ~63% of people whom
were either overweight or obese. LVM was determined using two-dimensional directed
M-mode echocardiography and indexed to height2.7 (LVMI). ~28% of the sample had LV
hypertrophy. Marked differences in plasma leptin concentrations were noted between
men and women. Thus, multivariate regression analysis was employed to identify
independent relations between plasma leptin concentrations and either LVMI or LV
mean wall thickness in sex-specific groups.
Before adjustments for potential confounders, plasma leptin concentrations were
associated with LVMI in both women (r=0.25, p<0.0001) and in men (r=0.20, p=0.017)
as well as with LV mean wall thickness in both women (r=0.22, p<0.001) and in men
(r=0.27, p=0.002). Moreover, participants with LV hypertrophy defined as an LVM index
of >51 g/m2 had markedly greater plasma leptin concentrations than those participants
without LV hypertrophy. However, plasma leptin concentrations were also associated
with age, conventional systolic blood pressure and with adiposity indices (p<0.0001),
factors that had robust relationships with LVMI and LV mean wall thickness. In
multivariate regression models with plasma leptin concentrations, adiposity indices, age,
systolic blood pressure and a number of alternative potential confounders in the same
regression model, although adiposity indices were strong independent predictors of both
LVMI and LV mean wall thickness in both women and men (p<0.002-p<0.0001), plasma
leptin concentrations were not independently related to either LVMI (p=0.32-0.96), or LV
mean wall thickness (p=0.33-0.81). In conclusion, plasma leptin concentrations, although
associated with, are not independent predictors of LVMI beyond adiposity indices and
other related factors in a population sample with a high prevalence of excess adiposity.
Therefore, plasma leptin concentrations are unlikely to predict cardiovascular risk
beyond conventional risk measurements because of an impact on LVM.

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:wits/oai:wiredspace.wits.ac.za:10539/7279
Date16 September 2009
CreatorsSookoo, Doodthnath Neil
Source SetsSouth African National ETD Portal
LanguageEnglish
Detected LanguageEnglish
TypeThesis
Formatapplication/pdf, application/pdf

Page generated in 0.0092 seconds